Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
IBER.U was delisted on the 1st of March, 2023.
60 hedge funds and large institutions have $120M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2021 Q1 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hartree Partners
New York
|
+$12.8M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$8.03M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.75M |
| 4 |
Millennium Management
New York
|
+$5.25M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
51
Bulldog Investors
Saddle Brook,
New Jersey
| $148K | +$150K | +15,000 | New |
|
|
E
52
Ergoteles
New York
| $137K | +$138K | +13,850 | New |
|
|
EMG
53
Ellington Management Group
Old Greenwich,
Connecticut
| $99K | +$100K | +10,000 | New |
|
|
HA
54
Harbor Advisors
West Palm Beach,
Florida
| $99K | +$100K | +10,000 | New |
|
|
PCM
55
Prelude Capital Management
New York
| $99K | +$100K | +10,000 | New |
|
|
WAM
56
Wolverine Asset Management
Chicago,
Illinois
| $98K | +$100K | +10,000 | New |
|
57
CI Investments Inc
Toronto,
Ontario, Canada
| $50K | +$51K | +5,100 | New |
|
|
CCM
58
Condor Capital Management
Martinsville,
New Jersey
| $23K | +$23.8K | +2,380 | New |
|
59
UBS Group
Zurich,
Switzerland
| $8K | +$8.4K | +840 | New |
|
60
Walleye Capital
New York
| $1.18K | +$1.2M | +120,000 | New |
|
IBER.U Hedge Fund Activity: Q1 2021 in Review
60 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) for Q1 2021, worth a combined $120M.
Buyers outnumbered sellers: 60 funds opened new IBER.U positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hartree Partners, opening a new position worth an estimated $12.8M.
- 60 institutional investors held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $120M of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant stock for Q1 2021.
- 60 funds opened new Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant positions in Q1 2021 and 0 closed out, a net change of +60 holders.
- The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant buyer in Q1 2021 was Hartree Partners, an estimated $12.8M added.
Based on aggregated 13F filings for Q1 2021.